Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-041903
Filing Date
2022-07-12
Accepted
2022-07-12 16:26:23
Documents
1
Period of Report
2022-07-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 14137
  Complete submission text file 0001209191-22-041903.txt   15438
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Issuer) CIK: 0001358762 (see all company filings)

EIN.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 234 CHURCH STREET, SUITE 1020 NEW HAVEN CT 06510
Business Address
Ryder Steven (Reporting) CIK: 0001872868 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37785 | Film No.: 221079385